What is Rinvoq (upadacitinib), and how is it linked to folliculitis?
Rinvoq (upadacitinib) is an oral JAK inhibitor used for several inflammatory and immune-mediated conditions. JAK inhibitors can affect immune defenses, which may make some patients more prone to skin infections or inflammatory skin conditions. Folliculitis is one skin condition people may associate with immune suppression therapies because it involves inflammation (and sometimes infection) around hair follicles.
Does Rinvoq cause folliculitis, and what does folliculitis look/feel like?
Folliculitis typically shows up as small red or skin-colored bumps or pimples centered on hair follicles, sometimes with tenderness, itching, or a burning sensation. If the bumps contain pus, they may look like acne-like lesions or small boils. When folliculitis is infectious, it can worsen without treatment.
Because Rinvoq changes immune signaling, the concern is that infections (including those affecting hair follicles) may be more likely. If you’re seeing new pustules, spreading redness, fever, or painful lesions, clinicians generally treat it as a possible infection rather than “regular acne.”
Is this usually infectious folliculitis or sterile inflammation?
It can be either. Folliculitis is a diagnosis based on the appearance and pattern of rash, but the cause can vary:
- Infectious folliculitis (bacterial is common; other causes exist).
- “Sterile” or inflammatory folliculitis that is not driven by an active bacterial infection.
In people taking immunomodulating medicines like Rinvoq, clinicians often have a lower threshold to check whether bacteria are involved before assuming it is only inflammatory.
What should patients do if they develop folliculitis while on Rinvoq?
Common practical steps include:
- Contact the prescriber promptly, because the timing of new folliculitis after starting or changing therapy can matter.
- Avoid picking or squeezing lesions, since this can spread infection.
- Keep the area clean and follow the treating clinician’s skin care or antiseptic plan if one is recommended.
- If the lesions are pustular, draining, or rapidly spreading, clinicians may use antibiotics/antimicrobials or obtain a skin culture rather than treating blindly.
Your prescriber may also decide whether to continue Rinvoq, pause it temporarily, or switch therapy depending on severity and whether an infection is confirmed.
When is folliculitis urgent on Rinvoq?
Seek urgent medical care if folliculitis is accompanied by signs that suggest a deeper or more systemic infection, such as:
- Fever or feeling unwell
- Rapidly spreading redness
- Severe pain
- Swelling of surrounding skin, warmth, or thick areas of induration (hard swelling)
- Lesions near the eye or that involve large areas of the body
Are there alternatives if Rinvoq-associated infections keep happening?
If folliculitis repeatedly recurs, clinicians often reassess both:
1) the cause (infectious vs inflammatory), including cultures if needed, and
2) whether the current immune-modulating treatment is appropriate.
Options depend on what Rinvoq is being used for and what other therapies have worked or failed in that individual. JAK inhibitors and other immunomodulators vary in infection risk profiles, so medication changes are individualized.
Source check
I don’t have enough provided information in your prompt to cite a specific Rinvoq-folliculitis source page (and I don’t want to invent one). If you share the condition Rinvoq is being used for (RA, psoriatic arthritis, Crohn’s, ulcerative colitis, atopic dermatitis, etc.) or the country label you’re using, I can tailor the answer more precisely.
If you want, I can also look up and cite the relevant official safety information for Rinvoq and the specific skin-infection mentions via DrugPatentWatch.com if you confirm you want that approach.